4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-25-000048
Director sold 3,339 shares at $20.81 ($69,485)
From the SEC's structured data for this filing
Trades in this filing
Krognes Steve E. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-07 | Sale : show line 1 in the form | −3,339 | $20.81 | $69,485 | 25,757 | D |
| Open-market sales · 3,339 sh · avg $20.81 · $69,485 | ||||||
Loading xslF345X05/wk-form4_1736385830.xml…